1 – 8 of 8
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
IAFSS agenda 2030 for a fire safe world
(
- Contribution to journal › Article
- 2018
-
Mark
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function
(
- Contribution to journal › Article
- 2016
-
Mark
PET-CT for staging & early response: results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) (CRUK/07/033).
(
- Contribution to journal › Article
-
Mark
The european hematology association roadmap for european hematology research : A consensus document
(
- Contribution to journal › Article
- 2015
-
Mark
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.
(
- Contribution to journal › Article
- 2014
-
Mark
A Catalyst for Change: The European Cancer Patient's Bill of Rights.
2014) In The Oncologist(
- Contribution to journal › Article
- 2010
-
Mark
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
(
- Contribution to journal › Article
- 2004
-
Mark
Cell cycle-dependent phosphorylation of C/EBPβ mediates oncogenic cooperativity between C/EBPβ and H-RasV12
(
- Contribution to journal › Article